Compare SMX Security Matters plc (SMX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SMX Security Matters plc vs State Street SPDR S&P Biotech ETF — how do they compare? SMX Security Matters plc trades at $3.79 (market cap $4.13M), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 2447.9× SMX Security Matters plc's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold SMX Security Matters plc for 21 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| SMX | XBI | |
|---|---|---|
Market Cap | $4.13M | $10.11B |
Volume | 124,362 | 12,903,266 |
Sector | Industrials | Broad Market / Factor |
52-Week High | $74.08K | $169.55 |
52-Week Low | $3.79 | $104.99 |
Typical Hold Time | 21 Days | 38 Days |
Enterprise Value | -$27.20M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SMX trades at $3.79, down 2.82% today, amid a bearish technical signal from moving averages despite oversold RSI readings. The company reported no revenue for 2025, with a net loss of $169.18 million and negative cash flow from operations, though financing activities provided a net cash inflow. Recent news highlights SMX's focus on recycled plastic verification and digital material passports, gaining media attention from outlets like Forbes and the Boston Herald in late 2026.
The outlook is highly speculative given the absence of revenue and deep losses; investment hinges on successful commercialization of its technology. Key risks include execution challenges, cash burn, and competitive pressures in the recycling sector. Analyst sentiment is cautious due to the lack of profitability and substantial financial deficits.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
